![Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[5-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fcas-image%2Fthumb-webp%2F308991-carbamic-acid-n-1r-2-2s-4s-2-5-111-dihydro-2-2s-5s-1-2s-2-methoxycarbonyl-amino-3-methyl-1-oxobutyl-5-methyl-2-pyrrolidinyl-2-benzopyrano-43-67-naphth-12-d-imidazol-9-yl-1h-imidazol-2-yl-4-methoxymethyl-1-pyrrolidinyl-2-oxo-1-phenylethyl-methyl.webp&w=3840&q=75)
CAS 1377049-84-7
:Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[5-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4′,3′:6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, methyl ester
Description:
Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[5-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4′,3′:6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, methyl ester, identified by CAS number 1377049-84-7, is a complex organic compound characterized by its intricate molecular structure, which includes multiple chiral centers and functional groups. This compound features a carbamic acid moiety, which is known for its role in various biological processes and potential pharmaceutical applications. The presence of multiple rings, including imidazole and pyrrolidine structures, suggests potential interactions with biological targets, making it of interest in medicinal chemistry. Additionally, the methoxycarbonyl and methoxymethyl groups may enhance its solubility and bioavailability. Overall, this compound exemplifies the complexity often found in drug-like molecules, with implications for its pharmacological properties and therapeutic potential.
Formula:C49H54N8O8
InChI:InChI=1S/C49H54N8O8/c1-26(2)41(54-48(60)63-5)47(59)57-27(3)12-17-38(57)45-51-36-16-14-30-20-35-33-15-13-31(19-32(33)25-65-40(35)21-34(30)43(36)53-45)37-22-50-44(52-37)39-18-28(24-62-4)23-56(39)46(58)42(55-49(61)64-6)29-10-8-7-9-11-29/h7-11,13-16,19-22,26-28,38-39,41-42H,12,17-18,23-25H2,1-6H3,(H,50,52)(H,51,53)(H,54,60)(H,55,61)/t27-,28-,38-,39-,41-,42+/m0/s1
InChI key:InChIKey=FHCUMDQMBHQXKK-CDIODLITSA-N
SMILES:C([C@@H](NC(OC)=O)C(C)C)(=O)N1[C@H](C=2NC=3C4=C(C=C5C(=C4)OCC=6C5=CC=C(C6)C=7NC(=NC7)[C@H]8N(C([C@H](NC(OC)=O)C9=CC=CC=C9)=O)C[C@@H](COC)C8)C=CC3N2)CC[C@@H]1C
Synonyms:- Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[4-[1,11-dihydro-2-[(2S,5S)-1-
- Carbamic acid, N-[(1R)-2-[(2S,4S)-2-[5-[1,11-dihydro-2-[(2S,5S)-1-[(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4′,3′:6,7]naphth[1,2-d]imidazol-9-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-, methyl ester
- Gs-5816
- Methyl [(2S)-1-[(2S,5S)-2-[9-[2-[(2S,4S)-1-[(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-1,11-dihydroisochromeno[4′,3′:6,7]naphtho[1,2-d]imidazol-2-yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
- Velpatasvir
- [(2S)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1H- imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinyl]-2-oxo-1-phenylethyl]-,methyl ester
Sort by
Purity (%)
0
100
|
0
|
50
|
90
|
95
|
100
Found 16 products.
Methyl [(2S)-1-[(2S,5S)-2-[9-[2-[(2S,4S)-1-[(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl]-4-(methoxymethyl)pyrrolidin-2-yl]-1H-imidazol-5-yl]-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-2-yl]-5-methylpyrrolidin-1-yl]-3-methyl-1-oxobutan-2-yl]carbamate
CAS:Formula:C49H54N8O8Purity:99%Color and Shape:SolidMolecular weight:883.0019Velpatasvir
CAS:Velpatasvir (GS-5816), also known as GS-5816, is a potent and selective Hepatitis C virus NS5A inhibitor.Formula:C49H54N8O8Purity:99.17% - 99.83%Color and Shape:SolidMolecular weight:883Velpatasvir
CAS:<p>Applications Velpatasvir is a NS5A inhibitor in patients with hepatitis C (HCV) infection.<br>References Gane, E. J., et al.: Gastroenterol., 151, 448 (2016); Feld, J. J., et al.: N. Engl. J. Med. 373, 2599 (2015);<br></p>Formula:C49H54N8O8Color and Shape:NeatMolecular weight:883.0Velpatasvir
CAS:<p>Antiviral; Hepatitis C virus NS5A antagonist</p>Formula:C49H54N8O8Purity:Min. 95 Area-%Color and Shape:White PowderMolecular weight:883 g/molBoc Velpatasvir Keto
CAS:Controlled ProductFormula:C44H51N7O8Color and Shape:NeatMolecular weight:805.93Velpatasvir-d5
CAS:Controlled ProductFormula:C49D5H49N8O8Color and Shape:NeatMolecular weight:888.033Ethoxy Velpatasvir
CAS:Controlled ProductFormula:C51H58N8O9Color and Shape:NeatMolecular weight:927.07Velpatasvir R Isomer (Imidazole)
CAS:Controlled ProductFormula:C49H54N8O8Color and Shape:NeatMolecular weight:883.0Velpatasvir-13CD3
CAS:Controlled ProductFormula:CC48D3H51N8O8Color and Shape:NeatMolecular weight:887.013Velpatasvir-13C2, D6
CAS:Controlled ProductFormula:C47C2H48D6N8O8Color and Shape:NeatMolecular weight:891.02
![Methyl [(2S)-1-[(2S,5S)-2-[9-[2-[(2S,4S)-1-[(2R)-2-[(methoxycarbonyl)amino]-2-phenylacetyl]-4-(met…](/_next/image/?url=https%3A%2Fstatic.cymitquimica.com%2Fproducts%2FIN%2Fthumb%2FDA0039NU.jpg&w=3840&q=75)
